Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioAge Labs
Biotech
GLP-1 enthusiasm pushes BioAge into new age with $170M series D
BioAge's $170 million series D pushes the company's cash runway into at least late 2026.
Max Bayer
Feb 13, 2024 8:00am
Lilly, BioAge to test muscle regeneration drug with tirzepatide
Oct 26, 2023 11:39am
Former Arena CEO takes over new RNA biotech—Chutes & Ladders
May 26, 2023 9:30am
BioAge picks up muscle-aging program from Amgen
Apr 14, 2021 7:00am